As of April 19, 2025, Korro Bio (KRRO) has a market cap of $0.13 billion USD. According to our data, Korro Bio is ranked No.7361 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.13 B |
-63.41%
|
Dec 31, 2024 | $0.36 B |
-20.57%
|
Dec 29, 2023 | $0.45 B |
-75.10%
|
Dec 30, 2022 | $1.80 B |
-24.95%
|
Dec 31, 2021 | $2.40 B |
-85.45%
|
Dec 31, 2020 | $16.52 B |
101.14%
|
Dec 31, 2019 | $8.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.20 B |
49.857 M
|
![]() France
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Verve Therapeutics
VERV
|
$0.41 B |
0.000 M
|
![]() USA
|
Market Cap | = | KRRO Stock Price | * | KRRO Shares Outstanding |
= | $13.90 | * | 9.39 M | |
= | $0.13 B |